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Introduction
The vasodilator capacity of the coronary circulation is a 
strong determinant of clinical outcomes in the setting of 
ischaemic heart disease [1–7]. The accurate identifica-
tion of this characteristic of the coronary circulation may 
therefore be an important diagnostic tool, since adequate 
treatment of patients with impaired vasodilator capacity 
may modulate clinical outcomes [3]. The coronary flow 
reserve (CFR), the ratio of coronary flow during coronary 
vasodilation to resting coronary flow [8, 9], reflects the 
most straightforward assessment of coronary vasodilator 
capacity. It also remains the most well-studied physiologi-
cal index reflecting coronary vasodilator function. Large 
clinical outcome studies have documented that normal CFR 
is uniformly associated with favorable clinical outcomes 
[1–7]. Similarly, abnormal CFR is uniformly associated 
with impaired clinical outcomes, which can be modified by 
coronary revascularization [3]. Nonetheless, CFR depends 
on both resting and vasodilated coronary hemodynam-
ics, and a theoretical concern remains that physiological 
changes in these conditions may inadvertently affect the 
CFR result. Such CFR values affected by physiological 
changes in resting flow would obviously be an inadequate 
reflection of the underlying pathophysiology [10]. To over-
come such limitations of CFR related to its sensitivity to 
physiological flow alterations, the coronary flow capacity 
(CFC) concept was introduced [11, 12]. CFC integrates 
CFR with maximal flow during coronary vasodilation into 
a comprehensive framework of coronary flow characteris-
tics to overcome these inherent limitations of CFR. This 
Review will discuss the concept of CFC, its promises in the 
setting of ischaemic heart disease, and its challenges both 
in theoretical and practical terms.
Abstract The vasodilator capacity of the coronary circu-
lation is an important diagnostic and prognostic character-
istic, and its accurate assessment is therefore an important 
frontier. The coronary flow capacity (CFC) concept was 
introduced to overcome the limitations associated with 
the use of coronary flow reserve (CFR) for this purpose, 
which are related to the sensitivity of CFR to physiological 
alterations in systemic and coronary hemodynamics. CFC 
was developed from positron emission tomography, and 
was subsequently extrapolated to invasive coronary physi-
ology. These studies suggest that CFC is a robust frame-
work for the identification of clinically relevant coronary 
flow abnormalities, and improves identification of patients 
at risk for adverse events over the use of CFR alone. This 
Review will discuss the concept of CFC, its promises in the 
setting of ischaemic heart disease, and its challenges both 
in theoretical and practical terms.
Keywords Coronary flow · Vasodilator reserve capacity · 
Coronary flow capacity · Coronary flow reserve
 * Tim P. van de Hoef 
 t.p.vandehoef@amc.uva.nl
1 AMC Heart Center, Academic Medical Center – University 
of Amsterdam, Room B2-250, Meibergdreef 9, 
1105 AZ Amsterdam, The Netherlands
2 Department of Cardiology, ISSSTE General Hospital, 
Querétaro, Mexico
3 Faculty of Medicine, Autonomous University of Querétaro, 
Querétaro, Mexico
4 Cardiovascular Institute, Hospital Universitario Clinico San 
Carlos, Madrid, Spain
 Int J Cardiovasc Imaging
1 3
The concept
From coronary flow reserve to coronary flow capacity
Myocardial ischaemia occurs when the maximally 
achievable myocardial perfusion is insufficient to meet 
myocardial demand. The moment at which ischaemia 
occurs is therefore determined by the available reserve 
vasodilator capacity from resting to maximally vasodi-
lated conditions. This concept is expressed in the princi-
ple of CFR, which has been applied to a wide spectrum 
of both invasive and non-invasive diagnostic techniques. 
CFR is, however, purportedly sensitive to physiological 
alterations in resting and maximally vasodilated coronary 
flow. This limitation has raised concerns that unappreci-
ated alterations may inadvertently render the index less 
efficient to identify pathological impairment of coronary 
vasodilatory capacity [10]. The sensitivity of CFR to 
physiological alterations in hemodynamics is found in the 
fact that such alterations may abolish part of the avail-
able vasodilator reserve due to physiological adaptation. 
In such cases, a reduction in CFR may therefore not be 
due to pathologically decreased vasodilator reserve, but 
may be a mere expression of altered resting or hyperae-
mic conditions. Despite the strong prognostic value doc-
umented repeatedly for CFR on a population level, such 
potential inaccuracy may limit the use of the index at the 
patient level. This has led to development of novel con-
cepts aiming to accurately document flow impairment in 
the coronary circulation.
The CFC concept is governed by the understanding that 
vascular beds perfused by vessels with severely reduced 
maximal flow and exhausted CFR will exhibit signs of 
ischemia. Conversely, the occurrence of signs of ischemia 
will be unlikely in myocardial territories perfused by ves-
sels showing high maximal flow or high CFR [11–13]. The 
rationale behind CFC relies on the fact that the combina-
tion of CFR with hyperemic flow comprehensively captures 
all relevant flow characteristics of the vasculature under 
investigation. For example, baseline flow may be physi-
ologically elevated in the setting of anxiety or increased 
myocardial workload, whereas maximal flow in such set-
tings will still be adequate. In this situation, CFR may be 
low while no signs or symptoms of ischemia occur: CFC 
would indicate normal flow capacity on the basis of nor-
mal maximal flow. Conversely, maximal flow may be 
reduced in patients on beta-blockade therapy, while basal 
flow can be low due to the beta-blockade effects, resulting 
in a normal CFR preventing signs or symptoms of induc-
ible ischemia: CFC would indicate a normal flow capacity 
on the basis of normal CFR. Hence, combining hyperemic 
flow with CFR conceivably provides a more comprehen-
sive assessment and overcomes many limitations of using 
CFR alone to diagnose clinically pertinent impairment of 
myocardial flow.
Positron emission tomography‑derived coronary flow 
capacity
The CFC concept was initially developed in the setting 
of positron emission tomography (PET) [11, 13]. As an 
important fundament of the CFC concept, Johnson and 
Gould defined PET CFR and maximal flow thresholds 
for definite or possible myocardial ischaemia [13]. In this 
study, definite myocardial ischaemia was defined as a new 
or worse perfusion defect during dipyridamole stress with 
significant ST-segment depression and/or severe angina 
requiring pharmacological treatment. Possible myocardial 
ischaemia was characterized by either 1 of these abnormali-
ties during dipyridamole stress testing. In 1674 sequen-
tial PET studies in 1370 patients, maximal stress flow of 
0.91 ml/min/g optimally identified definite ischaemia from 
no ischaemia with an area under the receiver-operator char-
acteristic curve (AUC) of 0.98, whereas maximal stress 
flow above 1.12  ml/min/g was rarely associated with any 
of these manifestations of myocardial ischaemia. Similarly, 
a CFR cut-off of 1.74 had an AUC for definite myocardial 
ischaemia of 0.91, and CFR above 2.03 was rarely associ-
ated with manifestations of myocardial ischaemia. On the 
basis of these thresholds of maximal stress flow and CFR, 
the initial CFC concept was introduced [11]. Johnson and 
Gould visualized the integration of PET CFR and maxi-
mal stress flow results by integrating these measures in a 
color-coded scatterplot, displaying the individual CFR and 
maximal flow measurements throughout the left ventricle 
(Figs. 1, 2). They subsequently suggested a schematic map 
of the left ventricle, colored by where the CFR and maxi-
mal flow data of each of the left ventricular regions falls 
on this scatter plot, producing a new map integrating spa-
tial localization within the left ventricle with a color-based 
interpretation of the flow capacity (Fig. 2). Hence, the con-
cept of CFC is based on rigorously defined PET thresholds 
for myocardial ischaemia, and allows to be incorporated 
in easily interpretable graphs. Although PET was used for 
these initial studies, the same concept theoretically applies 
to any imaging modality that allows to assess myocardial 
flow.
Doppler flow velocity derived coronary flow capacity
The original PET-derived concept of integrating CFR and 
maximal flow was extrapolated to the invasive CFC con-
cept derived from invasive coronary flow assessment to 
allow ad-hoc identification of pertinent flow abnormalities 
directly in the catheterization laboratory [12]. Importantly, 
for this purpose, invasive flow was assessed by the Doppler 
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flow velocity technique. This is important, since, in contrast 
with coronary thermodilution-derived coronary flow, the 
magnitude of coronary Doppler flow velocity is intrinsi-
cally corrected for the amount of perfused myocardial mass 
in the arterial distribution [14, 15]. Flow velocity in the 
coronary circulation is only mildly reduced at every bifur-
cation due to the diameter reduction of the daughter vessels 
that accompanies an increase in total cross-sectional area 
of the arterial bed downstream [16]. Since the reduction in 
coronary diameter with branching of the coronary tree is 
directly related to the amount of perfused myocardial mass 
by the observed laws of normalized shear stress [14, 15], 
flow velocity yields an inherent correction of absolute flow 
velocity values for the amount of perfused myocardial mass 
[12].
Analogous to the PET-derived concept, invasive coro-
nary flow was categorized into clinically meaningful ranges 
using thresholds of CFR and hyperaemic coronary flow 
velocity derived from invasive measurements. Four rel-
evant invasive CFC categories were identified (Fig. 3). The 
highest coronary flows are encountered in patients without 
significant epicardial coronary narrowing (normal flow 
capacity). The subsequent category depicts slightly reduced 
coronary flows; lower than in patients without epicardial 
narrowing, but of adequate magnitude to prevent myocar-
dial ischemia (mildly reduced flow capacity). Moderately 
Fig. 1  The coronary flow capacity concept derived from positron 
emission tomography on the basis of a scatter plot of CFR versus 
absolute stress flow. As coronary flow reserve (CFR) equals stress 
flow divided by rest flow, a 2-dimensional plot comprehensively cap-
tures the flow characteristics of the coronary circulation. Reproduced 
from Johnson and Gould [11], with permission
Fig. 2  Individual patient data 
incorporated into the coronary 
flow capacity concept. The 
captured rest and stress flow, 
and coronary flow reserve 
can be displayed within the 
coronary flow capacity scatter 
plot, and can be incorporated 
into a graphical map of the left 
ventricle. Reproduced from 
Johnson and Gould [11], with 
permission
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reduced flows lie within the range of flows reported to be 
related to inducible myocardial ischemia, and can produce 
some manifestations of myocardial ischemia (moderately 
reduced flow capacity). Finally, severely reduced flows 
lie below the lower flow threshold reported for myocar-
dial ischemia (severely reduced flow capacity). However, 
strictly defined thresholds for myocardial ischaemia, as 
are available for PET, are only available for invasive CFR, 
whereas no such thresholds exist for maximal invasive flow 
[17, 18]. Hence, the invasive CFC concept was based upon 
well-defined thresholds of invasive CFR, and the invasive 
maximal flow velocity values were matched to the CFR 
threshold according to the corresponding percentiles [12]. 
Normal CFC was defined as a CFR ≥ 2.8, as encountered 
in patients with risk factors for IHD without epicardial nar-
rowing [18], with its corresponding hAPV of ≥49.0 cm/s. 
Mildly reduced CFC was defined as a CFVR < 2.8 but 
>2.1, which reflects the upper limit of reported CFR cut-
off values for inducible ischemia [17], and the correspond-
ing hAPV of <49.0 and >33.0  cm/s, respectively. Mod-
erately reduced CFC was defined as CFR ≤ 2.1 and >1.7, 
analogous to the reported range of CFR cut-off values for 
inducible myocardial ischemia [17], and the correspond-
ing hAPV of ≤33.0 and >26.0 cm/s, respectively. Finally, 
severely reduced CFC was defined as a CFR ≤ 1.7, which is 
the lower limit of CFR cut-off values reported for inducible 
myocardial ischemia and analogous to the ischemic CFR 
threshold in non-invasive imaging [13, 17], and the corre-
sponding hAPV of ≤26.0 cm/s. The graphical representa-
tion of this concept is illustrated in Fig. 3.
The promises of coronary flow capacity
As described above, the CFC concept bears a strong the-
oretical fundament, and a strong validation using PET-
derived thresholds for myocardial ischemia. Moreover, it 
was documented that integrating both CFR and maximal 
flow velocity in the invasive CFC concept was associated 
with an improved discrimination of major adverse car-
diac events over CFR alone [12]. This is of distinct inter-
est, since a large proportion of abnormal CFR values were 
actually associated with normal or mildly reduced CFC 
(Fig. 4). These findings lend further support for the concept 
Fig. 3  Since coronary flow 
reserve (CFR) equals hyper-
emic to baseline average 
peak flow velocity (hAPV), 
a 2-dimensional map of CFR 
versus hAPV comprehensively 
describes the invasive flow 
characteristics of the coronary 
vasculature under investiga-
tion. Within this concept, four 
clinically meaningful categories 
are defined (coded with different 
colors in the graph) based on 
well-validated invasive CFR 
cut-off values and the corre-
sponding hAPV percentiles. See 
“Doppler flow velocity derived 
coronary flow capacity” section 
for details. Reproduced from 
van de Hoef et al. [12], with 
permission
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of CFC, and may form the basis of further studies regard-
ing the diagnostic and prognostic characteristics of the CFC 
concept. Clearly, a cross-modality diagnostic tool to iden-
tify pathological impairment of vasodilator capacity may 
provide a robust tool to identify patients in whom coronary 
revascularization may modulate clinical outcomes, which 
remains the biggest promise of the CFC concept.
The challenges for coronary flow capacity
The main challenges for the CFC concept lie in the fact 
that the development of the concept has until now been 
performed using two diagnostic modalities that differ 
distinctly. The fundamental validation was performed 
using PET imaging, where robust thresholds for myocar-
dial ischaemia are available for both CFR and maximal 
blood flow. However, despite a robust conceptual valida-
tion, no clinical data regarding the potential diagnostic or 
prognostic benefits of the CFC concept over CFR alone 
are available for PET-derived CFC. In contrast, the data 
supporting the clinical relevance of the CFC concept 
was derived from invasive coronary Doppler flow veloc-
ity measurements. However, a formal validation of the 
CFC concept for invasive coronary Doppler flow veloc-
ity is not available. This is important because, although 
robust ischaemia-derived cut-off values are available 
for Doppler flow velocity-derived CFR, no such thresh-
olds are available for maximal Doppler flow velocity. 
As such it becomes clear that there is evident need for 
further development of the concept in both PET-derived 
CFC and invasive CFC. For PET-derived CFC, clini-
cal data supporting its added value over CFR alone is 
required. For this purpose, it is important to adhere to the 
fundamental validation of the PET-derived CFC concept. 
Hence, it is important to use perfusion-territory specific 
data to evaluate its diagnostic and prognostic value. For 
the further development of the invasive CFC concept, it 
will be important to identify strict ischaemic thresholds 
for maximal flow velocity. Considering that Doppler flow 
velocity is intrinsically normalized for the perfused myo-
cardial mass, as discussed above, such thresholds should 
be identifiable, and these data may allow to optimize the 
accuracy of the invasive CFC concept.
Importantly, the patient population studied in the inva-
sive CFC study was a clinical population of patients with 
known coronary artery disease of intermediate angio-
graphic severity, whom were submitted to the catheteri-
zation laboratory for the purpose of physiological assess-
ment of epicardial coronary stenosis in the coronary 
artery assessed with Doppler flow velocity. This popula-
tion is likely different from a population routinely stud-
ied using PET, in many of whom no information may be 
available on the presence of epicardial coronary stenosis 
in the interrogated perfusion territory. In this regard, it 
is important to realize that CFC disregards any solitary 
changes in resting coronary flow that may lead to a reduc-
tion in CFR. Although solitary changes in resting flow 
may not carry the dominant prognostic information in 
stenosed coronary arteries, or at least may not discrimi-
nate between hemodynamically relevant or non-relevant 
coronary stenosis, the opposite may be true for non-
obstructed coronary arteries. For non-obstructed coro-
nary arteries, it has been well-documented that a reduced 
CFR due to a solitary increase in resting coronary flow 
carries important risk for adverse cardiac events [5, 6, 
19]. This has been documented both in stable ischaemic 
heart disease patients [5], as well as in post ST-segment 
myocardial infarction patients [6], and is likely linked to 
impaired function of the coronary autoregulatory mecha-
nism. No clinical outcome data on CFC in non-obstructed 
coronary arteries is available to date, so the concept can-
not be translated to this setting. Intuitively, CFC has a 
dominant application in the assessment of flow abnor-
malities in obstructed coronary arteries, where changes 
in resting flow do not relate to stenosis-induced coronary 
flow impairment and can thereby indeed be disregarded 
for decisions regarding stenosis revascularization. In 
non-obstructed coronary arteries, however, flow impair-
ment due to altered coronary autoregulation may impart 
significant prognostic value and should not routinely be 
discarded as confounding. Hence, it will be important 
to evaluate whether global myocardial CFC, or CFC in 
territories supplied by unobstructed vessels imparts the 
Fig. 4  Identification of severely reduced CFC by CFR. A large pro-
portion of patients with moderately to normal coronary flow capacity 
presented abnormal CFR values. CFC coronary flow capacity, CFR 
coronary flow reserve. (Adapted from van de Hoef et  al. [12], with 
permission)
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same prognostic value as CFC in territories supplied by 
vessels with epicardial obstruction, as were studied in the 
prognostic invasive CFC study.
Apart from the challenges in terms of validation of the 
CFC concept, the fact that the CFC relies on flow meas-
urements imparts a practical challenge as well. PET tech-
nology is only scarcely available. Similarly, the measure-
ment of invasive Doppler flow velocity requires specific 
measurement equipment, and distinct operator experience 
with the armamentarium. However, the CFC concept is 
theoretically applicable to all modalities that allow to 
measure coronary flow. As such, extrapolation of the con-
cept to a variety of modalities would create ample oppor-
tunity for its embedment in routine clinical practice.
Future outlook
Following the fundamental PET validation, and docu-
mented prognostic value in Doppler velocity, ample 
avenue for further research remains. Such efforts are 
facilitated by the fact that information to calculate CFC 
is available in any study that has measured CFR to date. 
Hence, re-analysis of large prospective studies on the 
prognostic value of CFR may be able to shed light on 
the added value of integrating maximal blood flow and 
CFR into the CFC concept, and whether the clinical ben-
efit of the CFC concept extends to both patients with and 
without obstructive coronary artery disease. Ultimately, 
it remains important to realize that coronary flow and 
flow reserve are the critical determinants of myocardial 
ischemia [20–22], and may therefore prove to be a use-
ful gatekeeper to coronary revascularization. For this, the 
potential of CFC to overcome limitations of using CFR 
alone, may push flow-based physiological assessment 
to be considered as a first-in-line diagnostic modality in 
ischaemic heart disease patients.
Conclusion
The CFC concept integrates CFR and maximal coronary 
flow to enhance identification of pathological flow impair-
ment compared with CFR alone. Such a tool provides a 
variety of opportunities to enhance diagnosis and progno-
sis in patients with ischaemic heart disease. Its fundamen-
tal validation by PET has left a robust conceptual frame-
work, and its extrapolation to invasive coronary physiology 
has suggested important diagnostic and prognostic ben-
efits. However, for its clinical application, many challenges 
remain to optimize the concept and identify in which set-
tings patients may benefit from its application.
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